Skip to content
live

Canada buys up millions more doses of Moderna's bivalent COVID-19 vaccine

The company's bivalent vaccine targets both the original strain of COVID-19 and the Omicron variant
20220822110852-fb9e079b5d173a1959db64f10fecf52c9ed343a9bb5648d0821ea23f12031d0c
Clinic volunteer Kelly Brown draws out Moderna vaccine during a drive through COVID-19 vaccine clinic at St. Lawrence College in Kingston, Ont., on January 2, 2022. THE CANADIAN PRESS/Lars Hagberg

OTTAWA — Moderna says the federal government has purchased a total of 12 million doses of the company's bivalent vaccine that targets both the original strain of COVID-19 and the Omicron variant.

Canada purchased 4.5 million new doses and pushed up the delivery date for the 1.5 million doses originally scheduled to arrive in Canada next year.

The government and the company also agreed to convert six million doses of the company's original COVID-19 Spikevax vaccine to bivalent doses.

The agreement depends on Health Canada's approval of the bivalent vaccine, which was submitted for review on June 30.

Last week, British regulators became the first in the world to authorize Moderna's vaccine that protects against both the original strain of the novel coronavirus and the Omicron BA.1 subvariant.

Health Canada is also reviewing a bivalent Omicron vaccine submission from Pfizer.

This report by The Canadian Press was first published Aug. 22, 2022.

Laura Osman, The Canadian Press

Rogers Sports & Media
6080 Young Street Halifax, NS, B3K 5L2
© 2006-2022 Rogers Sports & Media. All rights reserved.
push icon
Be the first to read breaking stories. Enable push notifications on your device. Disable anytime.
No thanks